These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls. Orologas AG, Buckman TD, Eiduson S. Neurosci Lett; 1986 Aug 04; 68(3):293-8. PubMed ID: 3748456 [Abstract] [Full Text] [Related]
13. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables. Buckman TD, Kling A, Sutphin MS, Steinberg A, Eiduson S. Psychiatry Res; 1990 Jan 04; 31(1):1-14. PubMed ID: 1969170 [Abstract] [Full Text] [Related]
14. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH. Am J Psychiatry; 1976 Apr 04; 133(4):438-40. PubMed ID: 1267046 [Abstract] [Full Text] [Related]
15. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics. Mann JJ, Kaplan RD, Georgotas A, Friedman E, Branchey M, Gershon S. Psychopharmacology (Berl); 1981 Apr 04; 74(4):344-8. PubMed ID: 6794079 [Abstract] [Full Text] [Related]
16. Poor outcome and low platelet MAO activity in chronic schizophrenia. Bierer L, Docherty JP, Young JG, Giller E, Cohen D. Am J Psychiatry; 1984 Feb 04; 141(2):257-60. PubMed ID: 6140867 [Abstract] [Full Text] [Related]
19. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis. Zureick JL, Meltzer HY. Biol Psychiatry; 1988 May 04; 24(1):63-78. PubMed ID: 3285902 [Abstract] [Full Text] [Related]
20. Paranoid schizophrenia and platelet MAO activity. Baron M, Perlman R, Levitt M. Am J Psychiatry; 1980 Nov 04; 137(11):1465-6. PubMed ID: 7435694 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]